{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T10:21:50Z","timestamp":1748168510911},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00115-017-0338-7","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T13:42:04Z","timestamp":1494510124000},"page":"929-941","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapie der Migr\u00e4ne"],"prefix":"10.1007","volume":"88","author":[{"given":"D.","family":"Holle-Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"N\u00e4gel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"key":"338_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","volume":"27","author":"L Stovner","year":"2007","unstructured":"Stovner L, Hagen K, Jensen R et\u00a0al (2007) The global burden of headache: a\u00a0documentation of headache prevalence and disability worldwide. Cephalalgia 27:193\u2013210","journal-title":"Cephalalgia"},{"key":"338_CR2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"338_CR3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-2982.2007.01316.x","volume":"27","author":"M Obermann","year":"2007","unstructured":"Obermann M, Yoon M\u2011S, Dommes P et al (2007) Prevalence of trigeminal autonomic symptoms in migraine: a\u00a0population-based study. Cephalalgia 27:504\u2013509","journal-title":"Cephalalgia"},{"key":"338_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/head.12482","volume":"55","author":"RC Burch","year":"2015","unstructured":"Burch RC, Loder S, Loder E, Smitherman TA (2015) The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 55:21\u201334","journal-title":"Headache"},{"key":"338_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","volume":"84","author":"RB Lipton","year":"2015","unstructured":"Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 84:688\u2013695","journal-title":"Neurology"},{"key":"338_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100118943","volume":"40","author":"I Worthington","year":"2013","unstructured":"Worthington I, Pringsheim T, Gawel MJ et\u00a0al (2013) Canadian headache society guideline: acute drug therapy for migraine headache. Can J Neurol Sci 40:1\u20133","journal-title":"Can J Neurol Sci"},{"key":"338_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1526-4610.2004.04049.x","volume":"44","author":"ML Diamond","year":"2004","unstructured":"Diamond ML, Hettiarachchi J, Hilliard B, Sands G, Nett R (2004) Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders. Headache 44:209\u2013216","journal-title":"Headache"},{"issue":"Suppl 4","key":"338_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/head.12601","volume":"55","author":"C Cameron","year":"2015","unstructured":"Cameron C, Kelly S, Hsieh S\u2011C et al (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 55(Suppl 4):221\u2013235","journal-title":"Headache"},{"key":"338_CR9","first-page":"CD009665","volume":"2012","author":"CJ Derry","year":"2012","unstructured":"Derry CJ, Derry S, Moore RA (2012) Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2012:CD009665","journal-title":"Cochrane Database Syst Rev"},{"key":"338_CR10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1468-2982.2003.00554.x","volume":"23","author":"M F\u00e4rkkil\u00e4","year":"2003","unstructured":"F\u00e4rkkil\u00e4 M, Olesen J, Dahl\u00f6f C et\u00a0al (2003) Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 23:463\u2013471","journal-title":"Cephalalgia"},{"key":"338_CR11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0333102413500726","volume":"34","author":"M Almas","year":"2014","unstructured":"Almas M, Tepper SJ, Landy S, Schweizer E, Ramos E (2014) Consistency of eletriptan in treating migraine: Results of a\u00a0randomized, within-patient multiple-dose study. Cephalalgia 34:126\u2013135","journal-title":"Cephalalgia"},{"key":"338_CR12","volume-title":"Therapie der Migr\u00e4ne. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie: Herausgegeben von der Kommission \u201eLeitlinien\u201c der DGN","author":"H-C Diener","year":"2012","unstructured":"Diener H\u2011C (2012) Therapie der Migr\u00e4ne. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie: Herausgegeben von der Kommission \u201eLeitlinien\u201c der DGN, 5.\u00a0Aufl. Thieme, Stuttgart","edition":"5"},{"key":"338_CR13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/head.12835","volume":"56","author":"SL Orr","year":"2016","unstructured":"Orr SL, Friedman BW, Christie S et\u00a0al (2016) Management of adults with acute migraine in the emergency department: the american headache society evidence assessment of parenteral pharmacotherapies. Headache 56:911\u2013940","journal-title":"Headache"},{"key":"338_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/archdischild-2012-303043","volume":"100","author":"M Cheelo","year":"2015","unstructured":"Cheelo M, Lodge CJ, Dharmage SC et al (2015) Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a\u00a0systematic review and meta-analysis. Arch Dis Child 100:81\u201389","journal-title":"Arch Dis Child"},{"key":"338_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw115","author":"CB Avella-Garcia","year":"2016","unstructured":"Avella-Garcia CB, Julvez J, Fortuny J et al (2016) Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms. Int J Epidemiol. doi: 10.1093\/ije\/dyw115","journal-title":"Int J Epidemiol"},{"key":"338_CR16","first-page":"298","volume":"22","author":"D Holle-Lee","year":"2015","unstructured":"Holle-Lee D, N\u00e4gel S, Solbach K (2015) Kopfschmerzmittel in der Schwangerschaft. Psychopharmakotherapie 22:298\u2013304","journal-title":"Psychopharmakotherapie"},{"key":"338_CR17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1526-4610.2009.01529.x","volume":"49","author":"M Cunnington","year":"2009","unstructured":"Cunnington M, Ephross S, Churchill P (2009) The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache 49:1414\u20131422","journal-title":"Headache"},{"key":"338_CR18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/head.12375","volume":"54","author":"SA Ephross","year":"2014","unstructured":"Ephross SA, Sinclair SM (2014) Final results from the 16-year Sumatriptan, Naratriptan, and Treximet pregnancy registry. Headache 54:1158\u20131172","journal-title":"Headache"},{"key":"338_CR19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00103-014-2002-8","volume":"57","author":"C Gaul","year":"2014","unstructured":"Gaul C (2014) Kopfschmerzen \u2013 Patientenschulung als Baustein multimodaler Therapieprogramme. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:961\u2013966","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"338_CR20","first-page":"8","volume":"7","author":"P Kropp","year":"2016","unstructured":"Kropp P, Meyer B, Dresler T et al (2016) Entspannungsverfahren und verhaltenstherapeutische Interven-tionen zur Behandlung der Migr\u00e4ne. Nervenheilkunde 7:8","journal-title":"Nervenheilkunde"},{"key":"338_CR21","unstructured":"Diener HC (2011) Valproins\u00e4ure: Was bei der Migr\u00e4neprophylaxe zu beachten ist. Dtsch Arztebl 108(8):A\u2011406\/B\u2011330\/C\u2011330"},{"key":"338_CR22","first-page":"12","volume":"112","author":"RWC Janzen","year":"2015","unstructured":"Janzen RWC, Gaul C (2015) Migr\u00e4neprophylaxe: Valproins\u00e4ure: Neues zum Off-Label-Use. Dtsch Arztebl Int 112:12","journal-title":"Dtsch Arztebl Int"},{"key":"338_CR23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s10194-015-0516-6","volume":"16","author":"C Gaul","year":"2015","unstructured":"Gaul C, Diener H\u2011C, Danesch U, Migravent\u00ae Study Group (2015) Improvement of migraine symptoms with a\u00a0proprietary supplement containing riboflavin, magnesium and Q10: a\u00a0randomized, placebo-controlled, double-blind, multicenter trial. J\u00a0Headache Pain 16:516","journal-title":"J Headache Pain"},{"key":"338_CR24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.phymed.2006.02.008","volume":"13","author":"R Agosti","year":"2006","unstructured":"Agosti R, Duke RK, Chrubasik JE, Chrubasik S (2006) Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a\u00a0systematic review. Phytomedicine 13:743\u2013746","journal-title":"Phytomedicine"},{"key":"338_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413515348","author":"LJ Stovner","year":"2013","unstructured":"Stovner LJ, Linde M, Gravdahl GB et al (2013) A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. doi: 10.1177\/0333102413515348","journal-title":"Cephalalgia"},{"key":"338_CR26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0b013e3182825055","volume":"80","author":"J Schoenen","year":"2013","unstructured":"Schoenen J, Vandersmissen B, Jeangette S et\u00a0al (2013) Migraine prevention with a\u00a0supraorbital transcutaneous stimulator: a\u00a0randomized controlled trial. Neurology 80:697\u2013704","journal-title":"Neurology"},{"key":"338_CR27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s10194-015-0543-3","volume":"16","author":"A Straube","year":"2015","unstructured":"Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R (2015) Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t\u2011VNS): a\u00a0randomized, monocentric clinical trial. J\u00a0Headache Pain 16:543","journal-title":"J Headache Pain"},{"key":"338_CR28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000002918","volume":"87","author":"SD Silberstein","year":"2016","unstructured":"Silberstein SD, Calhoun AH, Lipton RB et\u00a0al (2016) Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology 87:529\u2013538","journal-title":"Neurology"},{"key":"338_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1526-4610.2010.01800.x","volume":"51","author":"JR Couch","year":"2011","unstructured":"Couch JR (2011) Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache 51:33\u201351","journal-title":"Headache"},{"key":"338_CR30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"SK Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793\u2013803","journal-title":"Cephalalgia"},{"key":"338_CR31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","volume":"156","author":"E Cernuda-Moroll\u00f3n","year":"2015","unstructured":"Cernuda-Moroll\u00f3n E, Ram\u00f3n C, Mart\u00ednez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J (2015) OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 156:820\u2013824","journal-title":"Pain"},{"key":"338_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.124","author":"H-C Diener","year":"2016","unstructured":"Diener H\u2011C, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. doi: 10.1038\/nrneurol.2016.124","journal-title":"Nat Rev Neurol"},{"key":"338_CR33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1468-2982.2007.01488.x","volume":"28","author":"L Pageler","year":"2008","unstructured":"Pageler L, Katsarava Z, Diener HC, Limmroth V (2008) Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 28:152\u2013156","journal-title":"Cephalalgia"},{"key":"338_CR34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0333102412462638","volume":"33","author":"K Rabe","year":"2013","unstructured":"Rabe K, Pageler L, Gaul C et al (2013) Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a\u00a0randomized, double-blind, placebo-controlled study. Cephalalgia 33:202\u2013207","journal-title":"Cephalalgia"},{"key":"338_CR35","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S1474-4422(15)00198-2","volume":"14","author":"H-C Diener","year":"2015","unstructured":"Diener H\u2011C, Charles A, Goadsby PJ, Holle D (2015) New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol 14:1010\u20131022","journal-title":"Lancet Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0338-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0338-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0338-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T09:03:09Z","timestamp":1569315789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0338-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0338-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}